-+ 0.00%
-+ 0.00%
-+ 0.00%

ASTRAZENECA: BAXFENDY APPROVED IN US AS FIRST ALDOSTERONE SYNTHASE INHIBITOR TREATMENT FOR ADULTS WITH HYPERTENSION

Reuters·05/18/2026 06:00:00

Please log in to view news